The renin-angiotensin-aldosterone system plays an important role in the regulation of sodium and water homeostasis. Angiotensin-converting enzyme (ACE) is a metallopeptidase that converts the inactive decapeptide angiotensin I into the active octapeptide angiotensin II, which is a key component of the renin-angiotensin-aldosterone system. The ACE gene is located in chromosome 17 and its genetic variability may be a major regulator of ACE enzymatic activity. 1 The insertion of the 287 base pairs Alu fragment in intron 16 of the ACE gene, known as I/D polymorphism, explains 40% of the variability in ACE enzymatic activity across Caucasian race. 1 Human genetic studies suggest that I/D polymorphism is associated with endothelial dysfunction, early development of hypertension, atherosclerosis, myocardial infarction, and left ventricular function. 2, 3 Increased aortic stiffness and enhanced wave reflections are markers of cardiovascular disease and independent predictors of cardiovascular morbidity and mortality. Stiffening of large arteries leads to increased cardiac afterload, disturbed coronary perfusion, and mechanical fatigue of the arterial wall. Furthermore, increased arterial stiffness and wave reflections are implicated in the pathogenesis of systolic arterial hypertension. [4] [5] [6] Arterial stiffness is determined by genetic background and is affected by various factors including inflammation. [6] [7] [8] [9] Recent studies point toward a rather ambiguous relationship of the ACE I/D polymorphism with arterial stiffness in patients with cardiovascular risk factors or in disease states, [10] [11] [12] [13] [14] whereas few reports have shown a neutral association in healthy or low-risk populations. [10] [11] [12] 14 Furthermore, there is only limited data concerning wave reflections and ACE polymorphism. 15 Given the inconclusive data in this field, the aim of the present study was to investigate the role of ACE I/D polymorphism in both aortic stiffness and wave reflections in apparently healthy, low-risk population.
Methods
Study population. The study population consisted of 282 apparently healthy adults, randomly selected from the employees of two large industries producing food and cosmetics, located in Background Arterial stiffness is an important determinant of cardiovascular morbidity and mortality. The I/D polymorphism of angiotensinconverting enzyme (Ace) gene is associated with cardiovascular disease. However, the relationship between Ace polymorphism, arterial stiffness, and wave reflections in healthy, low-risk population has not been defined yet.
The study included 282 apparently healthy, low-risk individuals (mean age 39.7 ± 8.9 years, 178 males). carotid-femoral pulse wave velocity (PWV) was measured as an index of aortic stiffness, while wave reflections were assessed by augmentation index (AIx) of the central pressure waveform. I/D polymorphism of the Ace gene was determined in all subjects for the prevalence of the DD, ID, and II genotype (39, 44, and 17%, respectively). c-reactive protein (crP) levels were determined as a marker of chronic, subclinical inflammation.
results
After adjustment for potential confounding factors, presence of D allele was associated with lower values of PWV compared to II genotype (P < 0.05), implying lower aortic stiffness for D allele carriers. There was no association between Ace genotype and wave reflections or peripheral and central systolic pressures.
conclusions
In apparently healthy individuals, D allele is associated with lower aortic stiffness, whereas there is no association of the Ace polymorphism with wave reflections. This finding provides new insights into the possible links between Ace gene, regulation of large artery stiffness, and has implications for cardiovascular risk. 
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Athens, Greece. Subjects were from various socioeconomic categories, performed manual and office work, and all belonged to Caucasian race ( Table 1) . Subjects with hypertension (on drug therapy or with values of blood pressure >140/90 mm Hg), diabetes mellitus, cardiovascular disease (as defined by medical history, clinical examination and ECG), family history of premature vascular disease, and any acute inflammatory-infectious or chronic disease were excluded from the study. Subjects who were taking vasoactive medications were also excluded. The study protocol was approved by our Institutional Research Ethics Committee, and all participants gave informed written consent.
Study design. The study was conducted in the morning in a quiet, temperature-controlled room at 23 °C, and subjects underwent a detailed clinical interview and examination after abstaining from caffeine, ethanol, and flavonoid-containing beverages for at least 12 h before the study. Blood pressure was measured twice on the right arm and the average of two blood pressure values was used in the analyses. Baseline measurements for evaluation of arterial elastic properties and wave reflections were taken after a 20-min rest period in the supine position. Blood was drawn after performing baseline measurements for analysis of serum concentration of glucose, total cholesterol, triglycerides, and C-reactive protein (CRP).
Evaluation of arterial stiffness. Carotid-femoral pulse wave velocity (PWV), an established index of aortic stiffness, 4, 6, 7 was determined with the use of an automatic device (Complior, Artech Medical, Pantin, France) that allows online pulse wave recording and automatic calculation of PWV. Two different pulse waves were obtained simultaneously at two sites (at the base of the neck for the common carotid and over the right femoral artery) with two transducers. Distance was defined as the distance from the suprasternic notch to femoral artery minus the distance from the carotid artery to the suprasternic notch. Higher velocity of the pulse implies increased stiffness of the aorta.
Augmentation index (AIx) of the central (aortic) pressure waveform was measured as an index of wave reflections with a validated, commercially available system (SphygmoCor, version 7.01, SCOR 2000, AtCor Medical, Sydney, Australia) that uses the principle of applanation tonometry and appropriate acquisition and analysis software for noninvasive recording and analysis of the arterial pulse. [4] [5] [6] [7] AIx is a composite measure of the magnitude of wave reflections and arterial stiffness that affects timing of wave reflections. Augmented pressure, the pressure added to the incident wave by the returning reflected wave, represents the pressure boost caused by wave reflections that which the left ventricle must cope with. The AIx is defined as the augmented pressure divided by pulse pressure and is expressed as a percentage. Large values of AIx indicate increased wave reflections from the periphery and/ or earlier return of the reflected wave as a result of increased PWV (owing to increased arterial stiffness) and vice versa.
Repeatability of arterial function indexes. Our repeatability for determining PWV and AIx according to the Bland-Altman method was previously defined. 16 The repeatability coefficient was calculated as defined by the British Standard Institution, that is, according to the following formula:
where N is the sample size and di is the difference between the two measurements in a pair. The repeatability coefficient values were 0.575 m/s and 6.06% for PWV and AIx, respectively. 17 (5′GCCCTGCAGGTGTCTGCAGC3′, 5′TGCCCATAACAGGTCTTCATA3′). The procedure consisted of denaturation at 95 °C for 55 s, annealing at 60 °C for 55 s, extension at 72 °C for 60 s, repeated for 35 cycles followed by a final extension at 72 °C for 8 min. All samples described as DD underwent a second PCR using insertion-specific primers 17 5′TGGGACCACAGCGCCCGCCACTAC3′;5′TCGCCA GCCCTCCCATGCCCATAA3′ with identical PCR conditions (denaturation at 95 °C for 1 min, annealing at 62 °C for 50 s, extension at 72 °C for 50 s, and repeated for 35 cycles followed by a final extension at 72 °C for 8 min). After PCR was completed, 7 μl of each PCR product was loaded on 3% agarose gel and two independent investigators read pictures from each gel.
Determination of CRP. Serum was separated by centrifugation (3,500g at room temperature for 10 min) after acquisition of venous blood. High-sensitivity CRP was measured in serum by immunonephelometry (Dade Behring, Deerfield, IL; for 1.1 mg/l: intraassay precision 3.4%, interassay precision 3.8%).
Statistical analysis. ACE genotype was tested as a categorical variable (presence of 0, 1, 2 I alleles as group 1, 2, 3, respectively). The Hardy-Weinberg equilibrium was tested by using a χ 2 -test. The assumption of normality test for the dependent variables was tested using the Kolmogorov-Smirnov criterion. Normally distributed data are expressed as mean ± s.d. Nonnormally distributed variables were log-transformed, and they became normally distributed after transformation. These variables are presented in a nonlogarithmic format as median (25th-75th percentiles). The stiffness indexes were compared among subgroups of genotypes with analysis of covariance, in order to adjust for principal determinants of arterial elastic properties, such as age, gender, and blood pressure. When this analysis yielded a significant result, this finding was further tested with fully adjusted multiple linear regression analysis (including also heart rate, body mass index, smoking habits, total cholesterol, and levels of CRP as covariates). Statistical analysis was performed using SPSS 10.1 (Chicago, IL). Exact P values <0.05 were considered statistically significant. Sample size calculation was based on the hypothesis that different ACE genotypes would be associated with a difference of at least 0.6 m/s in PWV, which is satisfactory difference according to previously published studies. 10, 11 Therefore, on the basis of data from our unit showing that the standard deviation of PWV for subjects with characteristics similar to those of our study population was 1 m/s, we estimated that 45 subjects per genotype group (135 in total) would provide 80% power at the 5% level of significance to detect such a difference between groups of different genotypes.
results
Demographic characteristics of our population are shown in Table 1 . Distribution of ACE genotypes was consistent with the Hardy-Weinberg equilibrium. The proportion of each genotype in the population was: DD 39.4%, ID 43.6%, II 17%. The distribution of various demographic parameters did not differ among three groups ( Table 1) .
PWV
In analysis of covariance adjusting for age, gender, and mean arterial pressure, which are major determinants of arterial stiffness, we found a statistically significant difference in the levels of PWV among the three genotypes (estimated means: 6.52 m/s vs. 6.14 m/s vs. 6.29 m/s in the II, ID, and DD groups, respectively, P = 0.05). Using a recessive model analysis, we found that the presence of the D allele (DD plus ID vs. II) is In multiple linear regression analysis, we explored associations of the presence of the D allele with PWV after adjusting for a large number of potential confounding factors beyond age, gender, and mean arterial pressure, such as heart rate, body mass index, smoking habits, total cholesterol and levels of CRP, which are determinants of arterial elastic properties. The association between the presence of at least one D allele and lower values of PWV was significant and independent of these covariates ( Table 2 ). The presence of D allele predicted 1% of PWV variability.
Wave reflections and pressures
In analysis of covariance adjusting for age, gender, and mean arterial pressure, we did not find any association between ACE genotype and AIx (estimated means: 19.46% vs. 19.52% vs. 19.35% in the II, ID, and DD groups, respectively, P = 0.99) or augmented pressure (6.4 mm Hg vs. 7.1 mm Hg vs. 6.7 mm Hg in the II, ID, and DD groups, respectively, P = 0.53). Likewise, analysis revealed no effect of genotype on peripheral and central systolic, diastolic, and pulse pressures.
discussion
The results of the present study suggest that in apparently healthy, low-risk individuals the presence of D allele of the ACE genotype is associated with lower stiffness of the elastictype arteries such as the aorta, whereas there is no difference among the three genotypes regarding wave reflections.
The I/D polymorphism is believed to explain 40% of the variability observed in ACE activity in the general population, 1 with the D allele being associated with higher ACE activity. However, despite the strong association of I/D polymorphism with ACE enzymatic activity, findings on the relation of this polymorphism with hypertension are not consistent. 3, 18, 19 Accordingly, it is crucial to define whether and how this polymorphism affects arterial stiffness and wave reflections, which are implicated in the pathogenesis of systolic arterial hypertension. [4] [5] [6] Furthermore, increased aortic stiffness and enhanced wave reflections are markers of cardiovascular disease and independent predictors of cardiovascular morbidity and mortality. [4] [5] [6] Data regarding the association between I/D polymorphism and arterial stiffness are conflicting. [10] [11] [12] [13] [14] Previous reports showed an association between the presence of D allele and higher common carotid stiffness in a general population 12 and older subjects, 14 but failed to find a similar association with aortic stiffness. 14 Our results are in agreement with other studies conducted in diabetic patients, 10 in which the presence of I allele was consistent with higher values in aortic and carotid stiffness. Moreover, in a study performed in hypertensive and normotensive subjects, 11 PWV was higher in II genotype in the hypertensive group. The novelty of our study is that although in both the latter two studies 10, 11 no relationship was shown between the gene polymorphism and aortic stiffness in control/healthy groups, such a relationship could now be established in an apparently healthy, low-risk population.
Available literature data and findings of the present study taken together imply that genetic polymorphism may have a differential effect on arteries of different caliber and composition of their wall. All studies demonstrating an association of the D allele with higher arterial stiffness regard either the carotid artery or the femoral artery. 12, 14 Studies regarding the aorta have shown either absence of association, 10, 11, 13, 14 or a positive association between presence of I allele and higher stiffness (diabetic 10 and hypertensive 11 patients) or presence of D allele and lower stiffness (low-risk population: present study). Accordingly, although we move from smaller arteries with larger relative content of smooth muscle cells to larger arteries with less smooth muscle cells, the association with arterial stiffness progresses from positive for the presence of D allele to the opposite (negative for the D allele or positive for the I allele).
The aforementioned unifying hypothesis may explain the results regarding wave reflections. Indeed, genotype did not seem to exert any effect on AIx, a composite measure of arterial stiffness and tone of peripheral, smaller caliber muscular arteries. This is in line with a previous study 15 in which ACE genotype did not influence AIx in a general population. This could be explained by the fact that while D allele tends to decrease aortic stiffness and PWV (thus leading to a delayed return of the reflected wave), it tends also to increase peripheral vasoconstriction (increased ACE activity 1 ) and, consequently, the magnitude of the reflected wave, thus ultimately leading to a neutral net effect.
A limitation of our study is that we did not measure the plasma ACE levels of our subjects. Plasma and tissue ACE activity are increased in proportion to the number of D alleles. 1 Therefore, it would be anticipated that D allele is associated with higher aortic stiffness, which is in apparent contrast to the results of the present study. However, to our knowledge there are no available data to relate ACE levels and arterial stiffness. Existing data support that the regulation of aortic stiffness is a complex phenomenon and may also depend on pathways other than serum ACE levels. 11 For example, it is likely that the I/D polymorphism may be in linkage with other genetic loci, with a more important role in the regulation of arterial stiffness in large arteries than the variability in ACE enzymatic activity.
In conclusion, this is the first study to show that although the presence of D allele of the ACE genotype is associated with lower aortic stiffness, there is no association between ACE genotype and wave reflections in apparently healthy, low-risk population. This finding provides new insights into the possible links between ACE gene and regulation of large and small artery stiffness and tone. Given the prognostic role of aortic stiffness, the results of the present study may have important implications for cardiovascular risk.
